Literature DB >> 15870317

Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula.

Monique Haarman1, Jan Knol.   

Abstract

A healthy intestinal microbiota is considered to be important for priming of the infants' mucosal and systemic immunity. Breast-fed infants typically have an intestinal microbiota dominated by different Bifidobacterium species. It has been described that allergic infants have different levels of specific Bifidobacterium species than healthy infants. For the accurate quantification of Bifidobacterium adolescentis, Bifidobacterium angulatum, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium catenulatum, Bifidobacterium dentium, Bifidobacterium infantis, and Bifidobacterium longum in fecal samples, duplex 5' nuclease assays were developed. The assays, targeting rRNA gene intergenic spacer regions, were validated and compared with conventional PCR and fluorescent in situ hybridization methods. The 5' nuclease assays were subsequently used to determine the relative amounts of different Bifidobacterium species in fecal samples from infants receiving a standard formula or a standard formula supplemented with galacto- and fructo-oligosaccharides (OSF). A breast-fed group was studied in parallel as a reference. The results showed a significant increase in the total amount of fecal bifidobacteria (54.8% +/- 9.8% to 73.4% +/- 4.0%) in infants receiving the prebiotic formula (OSF), with a diversity of Bifidobacterium species similar to breast-fed infants. The intestinal microbiota of infants who received a standard formula seems to resemble a more adult-like distribution of bifidobacteria and contains relatively more B. catenulatum and B. adolescentis (2.71% +/- 1.92% and 8.11% +/- 4.12%, respectively, versus 0.15% +/- 0.11% and 1.38% +/- 0.98% for the OSF group). In conclusion, the specific prebiotic infant formula used induces a fecal microbiota that closely resembles the microbiota of breast-fed infants also at the level of the different Bifidobacterium species.

Entities:  

Mesh:

Year:  2005        PMID: 15870317      PMCID: PMC1087546          DOI: 10.1128/AEM.71.5.2318-2324.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  44 in total

Review 1.  Screening of intestinal microflora for effective probiotic bacteria.

Authors:  D J O'Sullivan
Journal:  J Agric Food Chem       Date:  2001-04       Impact factor: 5.279

2.  Contamination and sensitivity issues with a real-time universal 16S rRNA PCR.

Authors:  C E Corless; M Guiver; R Borrow; V Edwards-Jones; E B Kaczmarski; A J Fox
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers.

Authors:  J Walter; G W Tannock; A Tilsala-Timisjarvi; S Rodtong; D M Loach; K Munro; T Alatossava
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

4.  Basic principles of quantitative PCR.

Authors:  L Raeymaekers
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

5.  Differences in Bifidobacterium flora composition in allergic and healthy infants.

Authors:  A C Ouwehand; E Isolauri; F He; H Hashimoto; Y Benno; S Salminen
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

6.  Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction.

Authors:  P Brigidi; B Vitali; E Swennen; L Altomare; M Rossi; D Matteuzzi
Journal:  Syst Appl Microbiol       Date:  2000-10       Impact factor: 4.022

7.  Simultaneous identification of five bifidobacterium species isolated from human beings using multiple PCR primers.

Authors:  X Dong; G Cheng; W Jian
Journal:  Syst Appl Microbiol       Date:  2000-10       Impact factor: 4.022

Review 8.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2000-10       Impact factor: 5.098

9.  Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants.

Authors:  F He; A C Ouwehand; E Isolauri; H Hashimoto; Y Benno; S Salminen
Journal:  FEMS Immunol Med Microbiol       Date:  2001-02

10.  Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants.

Authors:  Jan Knol; Petra Scholtens; Corinna Kafka; Jochem Steenbakkers; Sabine Gro; Klaus Helm; Malte Klarczyk; Helmut Schöpfer; Heinz-Michael Böckler; John Wells
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-01       Impact factor: 2.839

View more
  78 in total

1.  Controlled gene expression in bifidobacteria by use of a bile-responsive element.

Authors:  Lorena Ruiz; Pablo Álvarez-Martín; Baltasar Mayo; Clara G de los Reyes-Gavilán; Miguel Gueimonde; Abelardo Margolles
Journal:  Appl Environ Microbiol       Date:  2011-11-11       Impact factor: 4.792

2.  Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene.

Authors:  Jana Junick; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

3.  Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections.

Authors:  José Antonio Moreno Muñoz; Empar Chenoll; Beatriz Casinos; Esther Bataller; Daniel Ramón; Salvador Genovés; Rebeca Montava; Juan Manuel Ribes; Javier Buesa; Joan Fàbrega; Montserrat Rivero
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

Review 4.  Breast milk oligosaccharides: structure-function relationships in the neonate.

Authors:  Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

5.  Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.

Authors:  Daniel J Merenstein; Tina P Tan; Aleksey Molokin; Keisha Herbin Smith; Robert F Roberts; Nawar M Shara; Mihriye Mete; Mary Ellen Sanders; Gloria Solano-Aguilar
Journal:  Gut Microbes       Date:  2015

6.  Human milk glycobiome and its impact on the infant gastrointestinal microbiota.

Authors:  Angela M Zivkovic; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

7.  Cultivating healthy growth and nutrition through the gut microbiota.

Authors:  Sathish Subramanian; Laura V Blanton; Steven A Frese; Mark Charbonneau; David A Mills; Jeffrey I Gordon
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

8.  A simple taurocholate-induced model of severe acute pancreatitis in rats.

Authors:  Zhong-Hui Liu; Jun-Sheng Peng; Chu-Jun Li; Zu-Li Yang; Jun Xiang; Hu Song; Xiao-Bing Wu; Jun-Rong Chen; De-Chang Diao
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

9.  Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants.

Authors:  Eline S Klaassens; Rolf J Boesten; Monique Haarman; Jan Knol; Frank H Schuren; Elaine E Vaughan; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

10.  A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer.

Authors:  Wei Tang; Yunfeng He; Shengcai Zhou; Yongping Ma; Geli Liu
Journal:  J Exp Clin Cancer Res       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.